Over-the-Counter Drugs Market In-Depth Analysis with Booming Trends Supporting Growth Till 2026

Over-the-Counter Drugs Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Over-the-Counter Drugs Market – Overview
Over-the-counter drugs, also known as non-prescription drugs, are available in pharmacies and other retail stores and
can be used without being prescribed by a doctor. These drugs are critical components of the pharmaceutical industry
as they are highly potent and have the capability to show effective results for simple diseases. The number of
competitors diving into the large pool of pharmaceutical industry are increasing day-by-day making the industry a
promising venture for new comers to capitalize upon.
This review will help to attain a competitive analysis of developments such as strategic alliances, mergers and
acquisition, joint ventures as well research and innovation leading to product development with respect to over-thecounter drugs market. According to Consumer Healthcare Products Association, the total U.S. sales for OTC medicines
accounted for US$ 34,327 million in 2017.
The global over-the-counter drugs market is highly competitive, owing to increasing adoption of personal healthcare
and self-medication due to rising awareness among the people regarding health precautions and basic drug knowledge.
Under such conditions, the competitors experience performance pressure in terms of pricing. Market players are thus
focusing on development of OTC drugs in cost-effective way that will help to cater price-sensitive customers, in turn,
significantly maintain and subsequently increase profit margins, especially in emerging economies.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Competitive Analysis - The top 10 players operating in the global over-the-counter drugs market
include:
1.
Pfizer, Inc. - Pfizer, Inc. is a global leading manufacturer and distributor of over-the-counter drugs, managing its
commercial operation through two major business segments namely, Pfizer Innovative Health and Pfizer Essential
Health. OTC drugs contribute to a major part of Innovative Health Segment, comprising annual revenue of US$
29,197 million in 2016. The company OTC drugs portfolio includes over 40 products, whereas the leading OTC
brands that generated significant revenue for Pfizer included Advil (Ibuprofen capsules for migraine) and Centrum
(Multivitamin Tablets), in 2016.
2.
Novartis AG - Novartis AG, is widely known for its research, development, manufacturing, and marketing of
healthcare products across the globe. Novartis operates its drugs business through two major operating channels
Innovative Medicine and Drugs manufactured by Sandoz which is a subsidiary of Novartis, has contributed to
positioning the company as one of the top players in global Over-the-counter drugs market. In March 2015, Novartis
OTC and GlaxoSmithKline Plc created a combined consumer healthcare business named GlaxoSmithKline
Consumer Healthcare Holdings Ltd, as a completely new entity, for which Novartis has an interest of 36.5% in the
investment and profit shares and the resulting pre-tax income from this alliance was valued at US$ 5.9 billion in
2016.
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1443
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Over-the-Counter Drugs Market: Key Players
●
Pfizer, Inc.,
●
Novartis AG
●
GlaxoSmithKline Plc
●
Bayer AG
●
Sanofi
●
Glenmark Pharmaceuticals
●
Merck KGaA
●
Teva Pharmaceuticals
●
Johnson & Johnson Services, Inc.
View this report @
https://www.coherentmarketinsights.com/ongoing-insight/over-the-counter-drugs-market-global-competitive-analysis-1443
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s ales@coh er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s ales@coh er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02

The global over-the-counter drugs market is highly competitive, owing to increasing adoption of personal healthcare and self-medication due to rising awareness among the people regarding health precautions and basic drug knowledge.